Lumosa Therapeutics Co Ltd
TPEX:6535
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lumosa Therapeutics Co Ltd
TPEX:6535
|
TW |
|
P
|
Power REIT
AMEX:PW
|
US |
|
Z
|
ZTE Corp
XMUN:FZM
|
CN |
|
Provaris Energy Ltd
F:WS90
|
AU |
|
H
|
Haemonetics Corp
SWB:HAZ
|
US |
|
Orange Belgium NV
F:MOS
|
BE |
|
ImpediMed Ltd
ASX:IPD
|
AU |
|
Kinepolis Group NV
F:KPSN
|
BE |
|
C
|
Colruyt Group NV
F:EFC1
|
BE |
|
L
|
LDC Dental PCL
SET:LDC
|
TH |
|
E
|
Econocom Group SE
F:1E91
|
BE |
|
P
|
Piraeus Bank SA
OTC:PIRBF
|
GR |
Bankruptcy Probability
Lumosa Therapeutics Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lumosa Therapeutics Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
L
|
Lumosa Therapeutics Co Ltd
TPEX:6535
|
13.6B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
622.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
352.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
336.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
159.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lumosa Therapeutics Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lumosa Therapeutics Co Ltd has no debt.
You can find a full breakdown on its Balance Sheet.